The Clinical Proteomic Tumor Analysis Consortium (CPTAC) database including 125 breast cancer patients and 18 normal patients showed that SFRP1 protein expression was downregulated (P < 0.0001) (Supplementary Figure 5E). Here, SFRP1 is linked to breast carcinoma.